Lumexa Imaging Holdings (NASDAQ:LMRI) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $0.07 by 381.69 percent. This is a 44.44 percent increase over losses of $(0.36) per share from the same period last year. The company reported quarterly sales of $267.734 million which beat the analyst consensus estimate of $261.206 million by 2.50 percent. This is a 7.95 percent increase over sales of $248.028 million the same period last year.